Research Paper Volume 15, Issue 8 pp 2863—2876

Identification of dual-purpose therapeutic targets implicated in aging and glioblastoma multiforme using PandaOmics - an AI-enabled biological target discovery platform


Figure 1. Overall workflow of the study. Current pipeline is designed to prioritize dual-purpose therapeutic targets by combining several data modalities following three distinct strategies of target identification. Potential target hypotheses are ranked using AI-driven scores obtained via PandaOmics TargetID engine and information regarding the combined expression, druggability, safety, novelty and accessibility by small molecules.